16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methylsulfonylamide,
16-phenoxytetranor-PGE2 methylsulfonylamide,
34.089 Pfizer,
5Z,13E-18R,11R,12R,15R- dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranor- 5,13-prostadienoic acid methylsulfonylamide,
CP-34089,
Nalador,
SHB 286,
sulproston,
sulprostone,
ZK-57671,
Sulprostone,
Nalador,
60325-46-4,
SHB 286,
CP-34089,
ZK-57671,
Sulprostone [USAN:INN],
Sulprostonum [INN-Latin],
Sulprostona [INN-Spanish],
UNII-501Q5EQ1GM,
C23H31NO7S,
EINECS 262-173-0,
CP 34089,
ZK 57671,
501Q5EQ1GM,
sulproston,
16-Phenoxy-omega-17,18,19,20-tetranor pge-2 methylsulfonylamide,
16-Phenoxy-17,18,19,20 tetranor prostaglandin E(sub 2) methyl sulfonylamide,
16-Phenoxy-omega-17,18,19,20-tetranor prostaglandin E2 methylsulfonylamide,
(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((E)-(3R)-(3-hydroxy-4-phenoxy-1-butenyl))-5-oxocyclopentyl)-N-(methylsulfonyl)-5-heptenamide,
Sulprostona,
Sulprostonum,
5-Heptenamide, 7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-N-(methylsulfonyl)-, (1R-(1alpha(Z),2beta(1E,3R*),3alpha))-,
34.089 Pfizer,
SHB-286,
NCGC00165899-01,
CP-34,089,
ZK 57 671,
16-phenoxytetranor-PGE2 methylsulfonylamide,
Sulprostone (USAN/INN),
AC1NSM49,
SCHEMBL94842,
GTPL1919,
CHEMBL1472830,
CHEBI:135755,
HMS3648J09,
16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methylsulfonylamide,
ZINC4474665,
2056AH,
MFCD00216056,
Sulprostone, >=95% (HPLC), oil,
AKOS024457401,
DB12708,
5-Heptenamide, 7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-N-(methylsulfonyl)-, (1R-(1a(Z),2b(1E,3R*),3a))-,
5Z,13E-18R,11R,12R,15R- dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranor- 5,13-prostadienoic acid methylsulfonylamide,
AN-39499,
LS-74543,
B7255,
D02725,
325S464,
SR-01000946436,
SR-01000946436-1,
BRD-K14551499-001-01-7,
(5Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3R)-3-hydroxy-4-buten-1-yl]-5-oxocyclopentyl]-N-(methylsulfonyl)-5-heptenamide,
(5Z,11alpha,13E,15R)--11,15-Dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranorprosta-5,13-dienoic acid methane sulfonamide,
(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4-(phenoxy)but-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide,
(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxy-but-1-enyl]-5-oxo-cyclopentyl]-N-methylsulfonyl-hept-5-enamide,
(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide,
5-Heptenamide, 7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-N-(methylsulfonyl)-, (1R-(1-alpha(Z),2-beta(1E,3R*),3-alpha))-,
Nalador (TN),
D0X2UE,
C23-H31-N-O7-S,
CID5312153,
C016767,
5-Heptenamide, 7-[3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl]-N-(methylsulfonyl)-, [1R-[1.alpha.(Z),2.beta.(1E,3R*),3.alpha.]]-,